|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 27 of 65 found articles
| Title: |
First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial |
| Author: |
Eichhorst, Barbara Fink, Anna-Maria Bahlo, Jasmin Busch, Raymonde Kovacs, Gabor Maurer, Christian Lange, Elisabeth Köppler, Hubert Kiehl, Michael Sökler, Martin Schlag, Rudolf Vehling-Kaiser, Ursula Köchling, Georg Plöger, Christoph Gregor, Michael Plesner, Torben Trneny, Marek Fischer, Kirsten Döhner, Harmut Kneba, Michael Wendtner, Clemens-Martin Klapper, Wolfram Kreuzer, Karl-Anton Stilgenbauer, Stephan Böttcher, Sebastian Hallek, Michael |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 17 (2016) nr. 7 pages 928-942 |
| Year: |
2016 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 27 of 65 found articles
| << previous | next >> |